Stern Chempharm LLP – FDA Inspection, Feb 8, 2019

Record Details

This FDA Inspection record concerns Stern Chempharm LLP, with an inspection on February 8, 2019, issued by the Office of Inspections and Investigations, covering human drugs.

Company: Stern Chempharm LLP
Inspection Date: February 8, 2019
Product Type: Human Drugs
Office: Office of Inspections and Investigations
Person: Marcus F. Yambot (FDA Associated Person)

View Company Profile

ID · d534eaf2-21a4-49ec-a483-822bf25c3c78

Inspection Facts

Inspection number: 1079013
FDA center: Human Drugs
Outcome: Form 483 issued

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Stern Chempharm LLP

FDA Inspection

Stern Chempharm LLPFebruary 8, 2019

Stern Chempharm LLP – FDA Inspection, Feb 8, 2019

Record Details

This FDA Inspection record concerns Stern Chempharm LLP, with an inspection on February 8, 2019, issued by the Office of Inspections and Investigations, covering human drugs.